Evidence map›Paper›PMID 39206752›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Ring Transformation of Cyclopropenes to Benzo-Fused Five-Membered Oxa- and Aza-Heterocycles via a Formal [4+1] Cyclization.

Fengyan Gu, Binyan Lin, Zhi-Huan Peng, Shijie Liu, Yuanqing Wu, Mei Luo, Ning Ding, Qichen Zhan, Peng Cao, Zhi Zhou and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fengyan GuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Binyan LinSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Zhi-Huan PengKey Laboratory of Molecular Target and Clinical Pharmacology & State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.
Shijie LiuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Yuanqing WuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Mei LuoSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Ning DingSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Qichen ZhanSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Peng CaoState Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
Zhi ZhouKey Laboratory of Molecular Target and Clinical Pharmacology & State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 511436, China.
Tao CaoSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.ORCID https://orcid.org/0000-0002-8309-5695

Funding

Jiangsu Provincial Medical Innovation Center CXZX202225Nanjing University of Chinese Medicine XPT22107052Nanjing University of Chinese Medicine XPT82204426National Key R&D Program of China 2023YFC2308200National Natural Science Foundation of China 22007020National Natural Science Foundation of China 22107052National Natural Science Foundation of China 82204426
6 · The paper itself

Abstract

In the context of the growing importance of heterocyclic compounds across various disciplines, numerous strategies for their construction have emerged. Exploiting the distinctive properties of cyclopropenes, this study introduces an innovative approach for the synthesis of benzo-fused five-membered oxa- and aza-heterocycles through a formal [4+1] cyclization and subsequent acid-catalyzed intramolecular O- to N- rearrangement. These transformations exhibit mild reaction conditions and a wide substrate scope. The applications in the late-stage modification of complex molecules and in the synthesis of a potential PD-L1 gene down-regulator, make this method highly appealing in related fields. Combined experimental mechanistic studies and DFT calculations demonstrate Rh(III)-mediated sequential C─H coupling/π-allylation/dynamically favorable O-attack route.

Indexed as

cyclopropenesDFT calculationsheterocycleslate‐stage modificationsrhodiumring transformation

Identifiers

PMID39206752
PMCPMC11516165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.